Artificial intelligence in mammography study - Trial ISRCTN60839016
Access comprehensive clinical trial information for ISRCTN60839016 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently status unknown. The study focuses on Malignant neoplasm of breast. Target enrollment is 68000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Imperial College London
National Institute for Health Research
Timeline & Enrollment
N/A
May 20, 2021
May 21, 2024
Summary
A novel AI system for breast cancer screening demonstrates the appropriate accuracy, safety, acceptability, and cost-effectiveness required for use as an independent reader within the NHS breast screening programme.
ICD-10 Classifications
Data Source
ISRCTN Registry
ISRCTN60839016
Non-Device Trial